Jpmorgan Chase & CO Third Harmonic Bio, Inc. Transaction History

Jpmorgan Chase & CO

$1.1 Trillion
Q1 2024

A detailed history of Jpmorgan Chase & CO transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 442,141 shares of THRD stock, worth $5.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

442,141

Previous 1,014,275 56.41%

Holding current value

$5.75 Million

Previous $11.1 Million 62.49%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$8.6 - $11.24 $4.92 Million - $6.43 Million	-572,134 Reduced 56.41%	442,141 $4.17 Million
Q4 2023 Feb 12, 2024	BUY	$5.97 - $11.47 $5.98 Million - $11.5 Million	1,001,315 Added 7726.2%	1,014,275 $11.1 Million
Q3 2023 Nov 14, 2023	SELL	$4.92 - $7.09 $12,614 - $18,178	-2,564 Reduced 16.52%	12,960 $82,000
Q2 2023 Aug 11, 2023	BUY	$4.18 - $5.33 $1,078 - $1,375	258 Added 1.69%	15,524 $74,000
Q1 2023 May 18, 2023	BUY	$3.95 - $4.49 $60,059 - $68,270	15,205 Added 24926.23%	15,266 $62,000

Q1 2023 May 11, 2023	SELL	$3.95 - $4.49 $74,327 - $84,488	-18,817 Reduced 99.68%	61 $0
Q4 2022 Feb 13, 2023	BUY	$4.0 - $22.0 $75,512 - $415,316	18,878 New	18,878 $81,000

Others Institutions Holding THRD

# of Institutions

Shares Held

35.8M

Call Options Held

Put Options Held

View Full List

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $524M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Third Harmonic Bio, Inc. Transaction History